For the Inventor, By the Inventor

Enter assignee name

Petach Tikva, Israel

Can-fite Biopharma Ltd.

USPTO Granted Patents = 22

CIPO Patents = 14

EPO Patents = 7

Trademarks = 8

Forward Citations = 61

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Pnina Fishman (17 out of 19 patents)

Shira Cohen (5 out of 5 patents)

Ilan Cohn (4 out of 6 patents)

4. Erica Van Tilburg (3 out of 3 patents)

5. Ad Ijzerman (3 out of 3 patents)

6. Lea Madi (2 out of 2 patents)

7. Kamel Khalili (1 out of 17 patents)

8. Xuejun Karl Liu (1 out of 5 patents)

9. Paul Bruzinski (1 out of 1 patent)

10. Cameron Gibb (1 out of 1 patent)

11. Pedro E HErnandez-Abad (1 out of 1 patent)

12. Mordechai Farbstein (1 out of 1 patent)

13. Sara Bar-Yehuda (1 out of 1 patent)

14. Tatiana Reitblat (1 out of 1 patent)

15. Sara Bar Yehuda (1 out of 1 patent)

22 patents: Sort by Forward Citations

1. 12213990 - A3 adenosine receptor ligand for use for achieving a fat loss effect (2025-02-04),

2. 11291681 - Method for treating fibrotic liver tissue using Cl-IB-MECA (2022-04-05),

3. 10780106 - Method for treating NASH accompanied by fibrosis using Cl-IB-MECA (2020-09-22),

4. 10265337 - Use of A3 adenosine receptor agonist in osteoarthritis treatment (2019-04-23),

5. 9549943 - A3 adenosine receptor ligands for use in treatment of a sexual dysfunction (2017-01-24),

6. 9387220 - Method for inducing hepatocyte proliferation and uses thereof (2016-07-12),

7. 9102698 - Process for the synthesis of IB-MECA (2015-08-11),

8. 8987228 - [object Object] (2015-03-24),

9. 8846635 - Method for inducing hepatocyte proliferation and uses thereof (2014-09-30),

10. 8557790 - A3 adenoside receptor agonists for the reduction of intraocular pressure (2013-10-15),

11. 8541182 - Biological marker for inflammation (2013-09-24),

12. 7825102 - Treatment of dry eye conditions (2010-11-02),

13. 7589075 - Use of an adenosine A3 receptor agonist for inhibition of viral replication (2009-09-15),

14. 7465715 - Method for treatment of multiple sclerosis (2008-12-16),

15. 7189706 - [object Object] (2007-03-13),

Can-Fite BioPharma Ltd. is a biotechnology company focused on the development of proprietary drugs that target inflammatory and cancerous diseases. The company's pipeline includes advanced drug candidates designed to treat a wide range of medical conditions such as psoriasis, liver cancer, rheumatoid arthritis, and more. With a strong emphasis on research and development, Can-Fite BioPharma is dedicated to bringing innovative therapies to market for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

22 Patents

#8 in Petach Tikva

#255 in Israel

#27,846 in the World

Petach Tikva, Israel

Can-fite Biopharma Ltd.

Forward Citations = 61

20 inventors:

Pnina Fishman (17 out of 19 patents)

Shira Cohen (5 out of 5 patents)

Ilan Cohn (4 out of 6 patents)

4. Erica Van Tilburg (3 out of 3 patents)

5. Ad Ijzerman (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…